Letter to the Shareholders – March 2018
We are pleased to inform that we have now received another MNOK 10,0 (tranche 2 of 3 tranches) from the investor consortium that joined us last fall…
We are pleased to inform that we have now received another MNOK 10,0 (tranche 2 of 3 tranches) from the investor consortium that joined us last fall…
Biovotec AS completes planned placement of NOK…
Minutes of the annual general meeting of Biovotec AS…
Biovotec and its partners have been awarded an R&D grant under the EU Eurostars program…
Biovotec has been awarded a Fast Track to Innovation grant under the SME Instrument financing scheme of the Horizon 2020…